[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 174.129.114.211. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Correspondence
May 2007

Measuring HRQOL in Patients With Cutaneous T-Cell Lymphoma Undergoing Therapy With Oral Bexarotene and Extracorporeal Photopheresis

Arch Dermatol. 2007;143(5):659-675. doi:10.1001/archderm.143.5.659

In a prospective pilot study, we investigated whether the combination of Skindex-291,2 and Functional Assessment of Cancer Therapy–General scale (FACT-G)1,3 provided relevant information during therapy on health-related quality of life (HRQOL) that would not be obtained from clinical assessment of patients with mycosis fungoides and/or Sézary syndrome (MF/SS).

First Page Preview View Large
First page PDF preview
First page PDF preview
×